Results 121 to 130 of about 26,062 (264)

Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.

open access: yesMolecular Genetics and Metabolism, 2020
K. Strauss   +24 more
semanticscholar   +1 more source

Biochemical Basis of Type IB (E1β) Mutations in Maple Syrup Urine Disease [PDF]

open access: hybrid, 2001
Richard Wynn   +4 more
openalex   +1 more source

Intramyelinic edema in maple syrup urine disease

open access: yesAnnals of Indian Academy of Neurology, 2014
Leema Pauline Cornelius   +3 more
doaj   +1 more source

Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data

open access: yesMolecular Genetics and Metabolism Reports, 2018
Incidence for the branched-chain intoxication-type disorders, maple syrup urine disease, propionic acidemia and methlymalonic aciduria is dependent on the population screened.
Kimberly A. Chapman   +3 more
doaj  

Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease [PDF]

open access: gold, 2003
Marco Henneke   +6 more
openalex   +1 more source

Structural and Biochemical Basis for Novel Mutations in Homozygous Israeli Maple Syrup Urine Disease Patients [PDF]

open access: hybrid, 2004
Jacinta L. Chuang   +7 more
openalex   +1 more source

Maple Syrup Urine Disease: An Uncommon Cause of Neonatal Febrile Seizures. [PDF]

open access: yesCureus, 2023
K K H   +4 more
europepmc   +1 more source

Testing Causal Explanations: A Case Study for Understanding the Effect of Interventions on Chronic Kidney Disease [PDF]

open access: yesarXiv
Randomized controlled trials (RCTs) are the standard for evaluating the effectiveness of clinical interventions. To address the limitations of RCTs on real-world populations, we developed a methodology that uses a large observational electronic health record (EHR) dataset.
arxiv  

Home - About - Disclaimer - Privacy